You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

Claims for Patent: 5,767,368


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,767,368
Title: Method for producting a cereal plant with foreign DNA
Abstract:A method for isolating a cereal plant with foreign DNA by bombarding meristem primordia tissue with particles coated with the foreign DNA in a culture media is described. The foreign DNA in the transformed plants can provide proteins which impart disease and/or insect resistance or other desirable properties.
Inventor(s): Zhong; Heng (East Lansing, MI), Sticklen; Masomeh B. (Okemos, MI)
Assignee: Board of Trustees operating Michigan State University (East Lansing, MI)
Application Number:08/415,426
Patent Claims:1. A method for producing a maize plant with foreign DNA encoding a herbicide or insecticide resistance which comprises:

(a) providing isolated shoot apex meristem primordia of germinated embryos of the maize which have been separated from a coleoptile and exposed by removal of leaf primordia of the plant in a first culture medium comprising a cytokinin selected from the group consisting of N.sub.6 -benzyladenine, 6-furfurylamino-purine and 6-(4-hydroxy-3-methylbut-2-enylamino)purine at a concentration between about 0.001 to 10 .mu.M and optionally an auxin selected from the group consisting of 3,6-dichloro-o-anisic acid, 2,4-dichlorophenoxyacetic acid, indole-3-acetic acid, indole-3-butyric acid and .alpha.-naphthaleneacetic acid at a concentration of between about 0.001 to 10 .mu.M with frequent subculturing over time to enable the meristem primordia to be transformed with the foreign DNA;

(b) bombarding the subcultured meristem primordia with micron sized particles coated with the foreign DNA to transform the meristem primordia with the DNA;

(c) growing the bombarded meristem primordia in a second culture medium containing the auxin and optionally the cytokinin and selecting for transformed meristem primordia using the herbicide; and

(d) regenerating the meristem primordia containing the foreign DNA in a culture medium containing the auxin to produce the transformed maize plant which has the herbicide or insect resistance.

2. The method of claim 1 wherein in addition the foreign DNA encodes an enzyme which is used as a visual selection marker.

3. The method of claim 2 wherein the enzyme is .beta.-glucuronidase.

4. The method of claim 1 wherein the first and second culture medium contains casein hydrolysate and N.sub.6 -benzyladenine and optionally 2,4-dichlorophenoxyacetic acid and the meristem primordia in step (a) are cultured in darkness for four weeks and then in the light for four weeks.

5. The method of claim 4 wherein the first culture medium and second culture medium contain MS medium.

6. The method of claim 5 wherein the first culture medium and second culture medium contain 0.5 to 1 g/liter casein hydrolysate and the 2,4-dichlorophenoxyacetic acid.

7. The method of claim 1 wherein the foreign DNA includes a promoter.

8. The method of claim 7 wherein the promoter is rice actin 1 promoter.

9. The method of claim 8 wherein the foreign DNA includes a 5' intron and a 5' non-coding exon.

10. The method of claim 1 wherein the foreign DNA encodes a bar gene for herbicide resistance.

11. The method of claim 1 wherein the foreign DNA encodes a pin 2 gene for insect resistance.

12. The method of claim 1 wherein the foreign DNA encodes a bar gene for resistance to glufosinate ammonium and a pin-2-gene for insect resistance.

13. The method of claim 1 wherein the foreign DNA is contained in plasmid pTW-a.

14. The method of claim 1 wherein the auxin in step (c) is indole-3-butyric acid (IBA).

15. The method of claim 14 wherein the indole-3-butyric acid is present in an amount between 0.001 and 10 .mu.M.

Details for Patent 5,767,368

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2039-02-26
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2039-02-26
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2039-02-26
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.